University Health System researchers discovered they could prevent diabetes from recurring in diabetic mice by transplanting insulin-manufacturing islet cells and then administering an anti-inflammatory drug called Lisofylline, according to a University Health System press release.
Researchers knew that transplantation was promising in treating type 1 diabetes. But the body destroyed islet cells without immune system-suppressing drugs.
The newly-created drug Lisofylline prevents cell destruction without the need for immune suppressants.
Researchers said their next step will be to test the drug in humans who have received islet cell transplants.
Read More
One week on, some students are still recovering after a field storming hospitalizes 19
By Lucia Gambacini | 7 hours agoWhile the field storm went viral online, some students said that the injuries were not worth the rush.
Student Council discusses community concerns regarding on-Grounds housing
By Lauren Seeliger | 19 hours agoThe University recently amended the on-Grounds housing policy to remove upperclassmen priority during the housing application process, effective for the 2026-27 housing application.
U.Va. among nine universities offered to join initiative led by Trump administration
By Brendon Bordwine | 23 hours agoThe Trump administration has sent out a letter outlining a proposed set of operating principles for universities that would give select universities preferential access to federal funding in exchange for adhering to certain conditions.
